scholarly journals McGill University Health Centre clinical fellowships

1997 ◽  
Vol 44 (12) ◽  
pp. N1-N1
Keyword(s):  
Health Centre ◽  
Mcgill University

scholarly journals Cannabis for Chronic Pain: Case Series and Implications for Clinicians

2002 ◽  
Vol 7 (2) ◽  
pp. 95-99 ◽  
Author(s):  
Mark A Ware ◽  
Ann Gamsa ◽  
Jan Persson ◽  
Mary-Ann Fitzcharles
Keyword(s):  
Chronic Pain ◽  
Health Centre ◽  
Case Series ◽  
Cannabis Use ◽  
Median Frequency ◽  
Median Dose ◽  
Night Time ◽  
Day Range ◽  
Frequency Of Use ◽  
Mcgill University

BACKGROUND:Chronic pain is one of the most common reasons for therapeutic cannabis use.OBJECTIVES:To describe therapeutic cannabis use among patients with chronic pain.METHODS:Patients with chronic pain who voluntarily indicated that they used cannabis therapeutically completed a questionnaire about the type of cannabis used, the mode of administration, the amount used and the frequency of use, and their perception of the effectiveness of cannabis on a set of pain-associated symptoms and side effects. The study was approved by the McGill University Health Centre Research Ethics Board.RESULTS:Fifteen patients (10 male) were interviewed (median age 49.5 years, range 24 to 68 years). All patients smoked herbal cannabis for therapeutic reasons (median duration of use six years, range two weeks to 37 years). Seven patients only smoked at night-time (median dose eight puffs, range two to eight puffs), and eight patients used cannabis mainly during the day (median dose three puffs, range two to eight puffs); the median frequency of use was four times per day (range one to 16 times per day). Twelve patients reported improvement in pain and mood, while 11 reported improvement in sleep. Eight patients reported a 'high'; six denied a 'high'. Tolerance to cannabis was not reported.CONCLUSIONS:The results of this self-selected case series must be interpreted with caution. Small doses of smoked cannabis may improve pain, mood and sleep in some patients with chronic pain. Clinical trials are warranted to test these effects. Further prospective studies should examine the patterns and prevalence of cannabis use among chronic pain populations.

scholarly journals Voice-Based Screening For SARS-CoV-2 Exposure In Cardiovascular Clinics

2021 ◽  
Author(s):  
Abhinav Sharma ◽  
Emily Oulousian ◽  
Jiayi Ni ◽  
Renato Lopes ◽  
Matthew Pellan Cheng ◽  
...  
Keyword(s):  
Healthcare Provider ◽  
Clinical Care ◽  
Health Centre ◽  
Healthcare Delivery ◽  
Signs And Symptoms ◽  
Kappa Statistic ◽  
Cohen’S Kappa ◽  
Cohen's Kappa ◽  
Mcgill University ◽  
Strongly Agree

Abstract Aims Artificial intelligence (A.I) driven voice-based assistants may facilitate data capture in clinical care and trials; however, the feasibility and accuracy of using such devices in a healthcare environment are unknown. We explored the feasibility of using the Amazon Alexa (‘Alexa’) A.I. voice-assistant to screen for risk-factors or symptoms relating to SARS-CoV-2 exposure in quaternary care cardiovascular clinics. Methods We enrolled participants to be screened for signs and symptoms of SARS-CoV-2 exposure by a healthcare provider and then subsequently by the Alexa. Our primary outcome was interrater reliability of Alexa to healthcare provider screening using Cohen’s Kappa statistic. Participants rated the Alexa in a post-study survey (scale of 1 to 5 with 5 reflecting strongly agree). This study was approved by the McGill University Health Centre ethics board. Results We prospectively enrolled 215 participants. The mean age was 46 years (17.7 years standard deviation [SD]), 55% were female, and 31% were French speakers (others were English). In total, 645 screening questions were delivered by Alexa. The Alexa mis-identified one response. The simple and weighted Cohen’s kappa statistic between Alexa and healthcare provider screening was 0.989 (95% CI: 0.982, 0.997) and 0.992 (955 CI 0.985, 0.999) respectively. The participants gave an overall mean rating of 4.4 (out of 5, 0.9 SD). Conclusion Our study demonstrates the feasibility of an A.I. driven multilingual voice-based assistant to collect data in the context of SARS-CoV-2 exposure screening. Future studies integrating such devices in cardiovascular healthcare delivery and clinical trials are warranted. Registration https://clinicaltrials.gov/ct2/show/NCT04508972

scholarly journals Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology

2021 ◽  
Vol 10 (1) ◽  
pp. e000934
Author(s):  
Arielle Elkrief ◽  
Genevieve Redstone ◽  
Luca Petruccelli ◽  
Alla'a Ali ◽  
Doneal Thomas ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Clinical Practice ◽  
Adjuvant Chemotherapy ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Cox Regression ◽  
Health Centre ◽  
Stage Iii ◽  
Stage Iii Colon Cancer ◽  
Mcgill University

PurposeAdjuvant chemotherapy within 56 or 84 days following curative resection is globally accepted as the standard of care for stage III colon cancer as it has been associated with improved overall survival. Initiation of adjuvant chemotherapy within this time frame is therefore recommended by clinical practice guidelines, including the European Society for Medical Oncology. The objective of this study was to evaluate adherence to these clinical practice guidelines for patients with stage III colon cancer across the Rossy Cancer Network (RCN); a partnership of McGill University’s Faculty of Medicine, McGill University Health Centre, Jewish General Hospital and St Mary’s Hospital Center.Patients and methods187 patients who had been diagnosed with stage III colon cancer and received adjuvant chemotherapy within the RCN partner hospitals from 2012 to 2015 were included. Patient and treatment information was retrospectively determined by chart review. Χ2 and Wilcoxon rank-sum tests were used to measure associations and a multivariate Cox regression model was used to determine risk factors contributing to delays in administration of adjuvant chemotherapy.ResultsThe median turnaround time between surgery and adjuvant chemotherapy was 69 days. Importantly, only 27% of patients met the 56-day target, and 71% met the 84-day target. Increasing age, having more than one surgical complication and being diagnosed between 2013–2014 and 2014–2015 reduced the likelihood that patients met these targets. Furthermore, delays were observed at most intervals from surgery to first adjuvant chemotherapy treatment.ConclusionOur study found that within these academic hospital settings, 27% of patients met the 56-day target, and 71% met the 84-day target. Delays were associated with hospital, surgeon and patient-related factors. Initiatives in quality improvement are needed in order to improve adherence to recommended treatment guidelines for prompt administration of adjuvant chemotherapy for stage III colon cancer.

scholarly journals A survey of health care professionals and oncology patients at the McGill University Health Centre reveals enthusiasm for establishing a postmortem rapid tissue donation program

2019 ◽  
Vol 26 (4) ◽  
Author(s):  
M. Dankner ◽  
J. Senecal ◽  
N. S. Neubarth ◽  
N. Bertos ◽  
M. Park ◽  
...  
Keyword(s):  
Health Care ◽  
Cancer Patients ◽  
Health Care Professionals ◽  
Current Knowledge ◽  
Metastatic Cancer ◽  
Health Centre ◽  
Tissue Donation ◽  
Developmental Phase ◽  
Oncology Patients ◽  
Mcgill University

Background  In the early developmental phase of a postmortem rapid tissue donation (RTD) program for patients with metastatic cancer, we surveyed health care professionals (HCPS) and oncology patients at the McGill University Health Centre (MUHC) to assess their knowledge and attitudes pertaining to RTD from metastatic cancer patients for research purposes.Methods   A 23-item survey was developed and distributed to hcps at tumour board meetings, and a related 26-item survey was developed and distributed to oncology patients at the MUHC Cedars Cancer Centre.Results   The survey attracted participation from 73 HCPS, including 37 attending physicians, and 102 oncology patients. Despite the fact that 88% of hcps rated their knowledge of RTD as none or limited, 42% indicated that they would feel comfortable discussing RTD with their cancer patients. Of the responding hcps, 67% indicated that their current knowledge of RTD would affect their decision to discuss such a program with patients, which implies the importance of education for hcps to facilitate enrolment of patients into a RTD program. Of responding patients, 78% indicated that they would not be uncomfortable if their doctor discussed RTD with them, and 61% indicated that they would like it if their doctor were to discuss RTD with them. The hcps and patients felt that the best time for patients to be approached about consenting to a RTD program would be at the transition to palliative care when no treatment options remain.Conclusions   At the MUHC, hcps and patients are generally enthusiastic about adopting a RTD program for patients with metastatic cancer. Education of hcps and patients will be an important determinant of the program’s success.

Developing pathways for cancer rehabilitation in tertiary oncology centers: Initial observations at the McGill University Health Centre.

2014 ◽  
Vol 32 (31_suppl) ◽  
pp. 17-17
Author(s):  
Sabrina Cesare ◽  
Irina Uscatescu ◽  
Jonathan di Tomasso ◽  
Lorella Ciutto ◽  
Kevin Yu-Chueh ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Handgrip Strength ◽  
Health Centre ◽  
Symptom Assessment ◽  
Well Being ◽  
Assessment System ◽  
Cancer Rehabilitation ◽  
Targeted Interventions ◽  
Mcgill University ◽  
Clinically Significant

17 Background: No definitive rehabilitation pathways exist for cancer patients. To address this gap, the Cancer Rehabilitation interdisciplinary team at the McGill University Health Centre has developed three program paths (e.g., Restorative, Supportive, and Cachexia) to meet the various specialized and personalized needs of cancer patients. Methods: A consecutive cohort of patients referred to the Cancer Rehabilitation Clinic between January 1st and June 30th, 2014 was considered. We examined the following baseline characteristics: handgrip strength (HGS), the abridged Patient Generated-Subjective Global Assessment (aPG-SGA) and Edmonton Symptom Assessment System (ESAS) self-reported questionnaires. Results: Of the 54 patients evaluated (57.4% male), 20 (mean age: 47.4 yrs), 8 (59.9 yrs) and 26 (64.6 yrs) were assigned to the restorative, supportive and cachexia streams, respectively. The most common cancer diagnoses were gastrointestinal (15%), gynecological (13%), breast (12%) and lung (12%). Table 1 contains baseline aPG-SGA, ESAS and HGS scores. Conclusions: Our preliminary data confirm clinically significant differences in muscle strength across the 3 streams for both males and females, as well as significant differences in nutritional, appetite and well-being scores between the patients in the restorative and cachexia pathways. Our data confirm the need of personalized and targeted interventions to achieve or maintain optimal performance and quality of life in cancer survivors with different disease and treatment characteristics. [Table: see text]

Collective Poetry Making in the Poesis of Psychohistoriographic Cultural Therapy

2021 ◽  
Vol 43 (1) ◽  
pp. 151-173
Author(s):  
Frederick W. Hickling ◽  
Hilary Robertson-Hickling ◽  
Debbie-Ann Chambers
Keyword(s):  
Mental Health ◽  
Cultural Diversity ◽  
Group Psychotherapy ◽  
Mental Hospital ◽  
Health Centre ◽  
Post Colonial ◽  
Cultural Therapy ◽  
Mental Health Centre ◽  
Mcgill University ◽  
Cooperative Association

Psychohistoriographic Cultural Therapy (PCT), pioneered in Jamaica in 1978, is a post-colonial model of group psychotherapy that privileges the use of the poetic to heal historical traumas. Embedded in PCT is a technique of collective poetry making. In this paper, the process is chronicled in five case studies: Madnificent Irations at the Bellevue Mental Hospital (Jamaica); Rethinking Cultural Diversity at the Cooperative Association of States for Scholarship (Georgetown University, Washington); Windows for Wavelengths at the Maudsley Hospital (London, UK); Identity and Achievement at the Afro-Caribbean Mental Health Centre (Wolverhampton, UK); and Mite de La Laine at the McGill University, (Montreal, Canada). An analysis of the PCT process and the collaborative poems created highlights how this model accelerates insight and resilience, confronts stigma, and facilitates rehabilitation and productivity.

scholarly journals Art at the McGill University Health Centre

2018 ◽  
Vol 190 (49) ◽  
pp. E1457-E1457
Author(s):  
Jonathan L. Meakins ◽  
Alexandra Kirsh
Keyword(s):  
Health Centre ◽  
Mcgill University

scholarly journals Outcome in Women with Traumatic Brain Injury Admitted to a Level 1 Trauma Center

2014 ◽  
Vol 2014 ◽  
pp. 1-9
Author(s):  
Elaine de Guise ◽  
Joanne LeBlanc ◽  
Jehane Dagher ◽  
Simon Tinawi ◽  
Julie Lamoureux ◽  
...  
Keyword(s):  
Traumatic Brain Injury ◽  
Brain Injury ◽  
Health Centre ◽  
Functional Independence Measure ◽  
Functional Independence ◽  
Discharge Destination ◽  
Confounding Variables ◽  
Mcgill University ◽  
Research Findings ◽  
Level 1 Trauma Center

Background. The aim of this study was to compare acute outcome between men and women after sustaining a traumatic brain injury (TBI). Methods. A total of 5,642 patients admitted to the Traumatic Brain Injury Program of the McGill University Health Centre-Montreal General Hospital between 2000 and 2011 and diagnosed with a TBI were included in the study. The overall percentage of women with TBI was 30.6% (n= 1728). Outcome measures included the length of stay (LOS), the Extended Glasgow Outcome Scale (GOSE), the functional independence measure instrument (FIM), discharge destination, and mortality rate. Results. LOS, GOSE, the FIM ratings, and discharge destination did not show significant differences between genders once controlling for several confounding variables and running the appropriate diagnostic tests (P<0.05). However, women had less chance of dying during their acute care hospitalization than men of the same age, with the same TBI severity and following the same mechanism of injury. Although gender was a statistically significant predictor, its contribution in explaining variation in mortality was small. Conclusion. More research is needed to better understand gender differences in mortality; as to date, the research findings remain inconclusive.

Sign in / Sign up

Export Citation Format

Share Document